Goldman Capital Management Raises Exposure to Mattersight Corporation (MATR)

Neil Goldman’s Goldman Capital Management revealed upping its stake in Mattersight Corporation (NASDAQ:MATR). According to a new filing with the SEC, Goldman currently owns over 1.18 million shares, versus 832,000 shares held at the end of September. The holding is passive by nature and amasses 6.3% of the company’s common stock. The position has a value of around $5.5 million, at the current price of Mattersight’s Corporation.

Last week, Mattersight Corporation (NASDAQ:MATR) closed a private placement of common stock under which it sold around 1.5 million shares to certain investors at the price of $3.90 apiece. Gross proceeds from the sale of securities amounted to $6.0 million, the company said in a statement. The proceeds will be used for different corporate and working capital purposes.

Mattersight Corporation (NASDAQ:MATR) is engaged in enterprise analytics software development. The company had a revenue of $25.2 million for the first nine months of 2013, slightly up from 25.1 million in the same period of last year. The company also managed to narrow its net loss in the January-September period, which totaled $9.6 million, versus $10.5 million a year ago.

Goldman’s move into Mattersight Corporation (NASDAQ:MATR), came together with several insiders buying shares of the company. According to our database, David Sweet, a large shareholder of Mattersight, recently acquired around 229,400 shares. Samuel Pullara, and Stefan Dyckerhoff, another two large shareholders, revealed buying some 229,600 shares each, among others. The insiders bought the stock at $3.90 per share, which is the same price as announced in the private placement.

Among hedge funds that we track, the only one that revealed holding shares of Mattersight Corporation (NASDAQ:MATR) is Jim Simons‘s Renaissance Technologies, which in its latest 13F, revealed ownership of 43,600 shares of Mattersight, worth $165,000.

Goldman, revealed increasing its position in Mattersight, right after, in an earlier filing, it disclosed cutting its position in Bacterin International Holdings Inc (NYSEMKT:BONE). Goldman reduced its exposure to the company to 1.5 million shares, from 2.5 million owned according to its latest 13F.

Disclosure: none

Recommended Reading:

Hedge Funds’ Latest Stock Picks: Carl Icahn, Steven Cohen And Others

Goldman Capital Management Reduces Stake in Bacterin International Holdings Inc (BONE)

SC Fundamental Value Fund Send Letter to Transcept Pharmaceuticals Inc (TSPT); Request Special Shareholder Meeting